The FDA is urging lawmakers to reauthorize a key user fee program that could expand access to over the counter medications, reducing barriers to treatment. At a recent hearing before the Senate Health ...

Health systems across the U.S. are investing heavily in IT overhauls, with some spending hundreds of millions to modernize infrastructure, integrate acquisitions and streamline operations. According ...

A new study has found a significant association between the use of GLP-1s such as Ozempic and Wegovy with a higher risk of developing a serious eye condition in patients with diabetes. Here are four t ...